OKYO Pharma Limited
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$16,825 over the previous period. Total operating expenses were $8,243.

Profit Margin

OKYO Pharma Limited (NASDAQ:OKYO): Profit margin
2015 0 -8.25M
2016 0 -820.17K
2017 0 -241.92K
2018 0 -28.26M
2019 0 -4.90M
2020 0 -1.54M
2021 0 -3.35M
2022 0 -5.43M
2023 0 -13.27M
2024 0 -16.82K

OKYO Income Statement (2015 โ€“ 2024)

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue
Revenue
0000000000
Cost of revenue
7.50K3.79K2.42K13.08K5.97K2190000
Gross profit
-7.50K-3.79K-2.42K-13.08K-5.97K-2190000
Operating exp.
Research and development
8.24K6.33M1.60M348.34K517.45K3.04M0000
Selling and marketing
0000000000
Total operating expenses
8.24K13.18M6.21M3.36M1.51M4.53M1.04M363.26K1.09M1.75M
Operating income
-15.74K-13.18M-6.21M-4.13M-1.51M-4.53M-28.25M-363.26K-1.12M-1.75M
Other income (expenses), net
-1.05K-96.68K13.57K754.84K-99.49K-363.04K-12.42K121.34K75.46K0
Income before tax
-16.80K-13.28M-6.21M-3.37M-1.61M-4.90M-28.26M-241.92K-1.01M-1.49M
Income tax expense
22-12.20K-786.52K-24.99K-76.19K00-56.93K-189.98K6.76M
Net income
-16.82K-13.27M-5.43M-3.35M-1.54M-4.90M-28.26M-241.92K-820.17K-8.25M
Earnings per share
Basic EPS
-0.00-0.6-0.00-0.00-0.00-0.00-0.07-0.00-0.00-0.02
Diluted EPS
-0.00-0.6-0.00-0.00-0.00-0.00-0.07-0.00-0.00-0.02
Data sourceData sourceData source